Financial Contrast: Curaleaf (OTCMKTS:CURLF) vs. PacificHealth Laboratories (OTCMKTS:PHLI)

PacificHealth Laboratories (OTCMKTS:PHLI) and Curaleaf (OTCMKTS:CURLF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Profitability

This table compares PacificHealth Laboratories and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PacificHealth Laboratories	N/A	N/A	N/A
Curaleaf	-18.59%	-14.75%	-5.19%

Institutional & Insider Ownership

0.0% of Curaleaf shares are owned by institutional investors. 38.0% of PacificHealth Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for PacificHealth Laboratories and Curaleaf, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PacificHealth Laboratories	0	0	0	0	N/A
Curaleaf	0	0	1	0	3.00

Curaleaf has a consensus target price of $6.25, suggesting a potential upside of 111.15%.

Risk & Volatility

PacificHealth Laboratories has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Curaleaf has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

Valuation and Earnings

This table compares PacificHealth Laboratories and Curaleaf”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PacificHealth Laboratories	N/A	N/A	N/A	N/A	N/A
Curaleaf	$1.35 billion	1.43	-$281.20 million	($0.35)	-8.46

PacificHealth Laboratories has higher earnings, but lower revenue than Curaleaf.

About PacificHealth Laboratories

PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.